Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Lucira Health, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +10 vs. Q3 2021
- Shares held
- 24.6M
- +6.84M (+38.6%) vs. Q3 2021
- Total value
- $211.6M
- +$79.8M (+60.5%) vs. Q3 2021
- New holders
- 20
- 12 more added
- Sold out
- 10
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LHDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $321 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $545 |
| Q1 2023 | 6 | $1.46M |
| Q4 2022 | 29 | $1.04M |
| Q3 2022 | 28 | $24.2M |
| Q2 2022 | 38 | $42.2M |
| Q1 2022 | 40 | $83.7M |
| Q4 2021 | 46 | $211.6M |
| Q3 2021 | 36 | $131.9M |
| Q2 2021 | 44 | $107.9M |
| Q1 2021 | 51 | $233.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Lucira Health, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | +50 | New |
| Tower Research Capital LLC (TRC) | 169 | $1.00K | 0.00% | +169 | New |
| Snowden Capital Advisors LLC | 340 | $2.00K | 0.00% | +340 | New |
| Captrust Financial Advisors | 319 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 463 | $4.00K | 0.00% | +463 | New |
| UBS Group AG | 1,772 | $15.0K | 0.00% | +625+54.5% | Added |
| Group One Trading, L.P. | 4,103 | $35.0K | 0.00% | +4,103 | New |
| Bank of America Corp | 9,582 | $83.0K | 0.00% | +9,582 | New |
| Johnson Financial Group, Inc. | 10,000 | $86.0K | 0.01% | 00.0% | Unchanged |
| Walleye Capital LLC | 10,915 | $94.0K | 0.00% | +10,915 | New |
| TrinityPoint Wealth, LLC | 11,000 | $95.0K | 0.02% | −3,250−22.8% | Reduced |
| ExodusPoint Capital Management, LP | 11,300 | $97.0K | 0.00% | +11,300 | New |
| Royal Bank of Canada | 11,660 | $100.0K | 0.00% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 11,855 | $106.0K | 0.00% | −2,275−16.1% | Reduced |
| Morgan Stanley | 12,558 | $109.0K | 0.00% | −1,415−10.1% | Reduced |
| Man Group plc | 12,669 | $109.0K | 0.00% | +12,669 | New |
| Paloma Partners Management Co | 13,084 | $113.0K | 0.00% | +13,084 | New |
| Cypress Point Wealth Management, LLC | 14,177 | $122.0K | 0.11% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 15,629 | $135.0K | 0.00% | +15,629 | New |
| Northern Trust Corp | 17,414 | $150.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 17,400 | $150.0K | 0.00% | +7,200+70.6% | Added |
| Resolute Partners Group | 22,800 | $196.0K | 0.01% | 00.0% | Unchanged |
| CastleKnight Management LP | 22,800 | $196.0K | 0.07% | +22,800 | New |
| Cutler Group LP | 28,272 | $243.0K | 0.02% | +26,872+1,919.4% | Added |
| Citadel Advisors LLC | 35,544 | $306.0K | 0.00% | −15,838−30.8% | Reduced |
| 683 Capital Management, LLC | 41,629 | $358.0K | 0.02% | +41,629 | New |
| BlackRock Inc. | 43,337 | $373.0K | 0.00% | −10,824−20.0% | Reduced |
| Papp L Roy & Associates | 45,500 | $392.0K | 0.04% | −350−0.8% | Reduced |
| State Street Corp | 49,500 | $426.0K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 55,479 | $478.0K | 0.13% | +55,479 | New |
| Simplex Trading, LLC | 60,932 | $524.0K | 0.02% | +60,889+141,602.3% | Added |
| Qube Research & Technologies Ltd | 64,729 | $557.0K | 0.00% | +64,729 | New |
| Ieq Capital, LLC | 73,205 | $630.0K | 0.01% | +27,030+58.5% | Added |
| D. E. Shaw & Co., Inc. | 74,565 | $642.0K | 0.00% | +74,565 | New |
| Wells Fargo & Company | 80,387 | $692.0K | 0.00% | −494−0.6% | Reduced |
| Geode Capital Management, LLC | 93,436 | $804.0K | 0.00% | +9,349+11.1% | Added |
| Consilio Wealth Advisors, LLC | 97,518 | $840.0K | 0.65% | +97,518 | New |
| Susquehanna International Group, LLP | 164,512 | $1.42M | 0.00% | +56,541+52.4% | Added |
| Parian Global Management LP | 183,804 | $1.58M | 1.43% | +183,804 | New |
| Data Collective II GP, LLC | 296,227 | $2.55M | 2.66% | +296,227 | New |
| Millennium Management LLC | 446,301 | $3.84M | 0.00% | +225,317+102.0% | Added |
| Vanguard Group Inc | 511,838 | $4.41M | 0.00% | +63,384+14.1% | Added |
| Silverarc Capital Management, LLC | 515,000 | $4.43M | 1.99% | +294,242+133.3% | Added |
| Pura Vida Investments, LLC | 1,165,230 | $10.0M | 1.05% | +163,288+16.3% | Added |
| Eclipse Ventures, LLC | 6,223,795 | $53.6M | 8.95% | +6,223,795 | New |
| EPIQ Capital Group, LLC | 13,996,250 | $120.5M | 21.41% | +200,067+1.5% | Added |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −578,114−100.0% | Sold out |
| Board of Trustees of The Leland Stanford Junior University | 0 | $0 | 0.00% | −124,459−100.0% | Sold out |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −485,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −93,439−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −57,684−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −27,487−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −15,331−100.0% | Sold out |
| Needham Investment Management LLC | 0 | $0 | 0.00% | −13,672−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −40−100.0% | Sold out |